Enlivex Ltd. (ENLV) Live Share Price, Invest From India

Enlivex Ltd. Stock Performance

as on June 27, 2026 at 2:15 pm IST

Day's Low
Day's High
$0.56
Day's Price Range
$0.60
$0.57
1.75%
Downside
5.26%
Upside
52 Week's Low
52 Week's High
$0.57
52-Week Price Range
$2.10
$0.57
0.35%
Downside
268.42%
Upside

Enlivex Ltd. share price movements today

Previous Close: $0.58
Open: $0.58
Volume: 644.2K
Day's Low - High: $0.56 - $0.60
52 Week Low - High: $0.57 - $2.10

Enlivex Ltd. Historical Returns

1 Month Return: -15.13 %
3 Month Return: -46.74 %
1 Year Return: -52.02 %
3 Year Return: -78.5 %
5 Year Return: -93.74 %

Enlivex Ltd. Stock Fundamentals & Key Indicators

Check Enlivex Ltd. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$145.9M

EPS (TTM)

-0.05

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0.02

Industry PE ratio

-3.9121076233183856

PEG Ratio

EBITDA

-14.7M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

126.17%

Enlivex Ltd. Stock Valuation

Track how Enlivex Ltd. P/E has moved over time to understand its valuation trends.

Enlivex Ltd. in the last 5 years

Overview
Trends

Lowest (-13.02x)

June 30, 2021

Industry (-3.91x)

June 26, 2026

Today (0.02x)

June 26, 2026

Highest (-1.07x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: 0.02x

Enlivex Ltd. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Enlivex Ltd. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Enlivex Ltd.	BUY	$145.9M	-93.74%	0.02	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$39.3B	67.15%	74.07	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$120.6B	147.08%	28.17	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$65.4B	12.64%	15.22	29.65%	0.58%

Stock Returns calculator for Enlivex Ltd. Stock including INR - Dollar returns

The Enlivex Ltd. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Enlivex Ltd. investment value today

Current value as on today

₹51,835

Returns

-₹48,165

(-48.17%)

Returns from Enlivex Ltd. Stock

-₹52,893 (-52.89%)

Dollar Impact

₹4,727 (+4.73%)

Analyst Recommendation on Enlivex Ltd. Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Enlivex Ltd.. Average target price of $20

Enlivex Ltd. Share Price Target

Get share price movements and forecasts by analysts on Enlivex Ltd..

What analysts predicted

97.15%UPSIDE

Target Price

$20

Current Price

$0.57

Analyzed by

7 Analysts

Target

$20.00

Enlivex Ltd. target price $20, a slight upside of 97.15% compared to current price of $0.57. According to 7 analysts rating.

Indian Investors' Interest in Enlivex Ltd. Stock

Search interest for Enlivex Ltd. Stock has increased by 73% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 30, 2026 to June 29, 2026

Change:73% versus previous 30 day period

Enlivex Ltd. Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	-	0	0	0	0
Operating Income	-5	-6	-3	-2	-3	-4	-3	-3	-2	-5
EBITDA	-5	-5	-3	-2	-2	-	-3	-2	-2	-5
Interest Expense	-	-	-	0	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-5	-9	-4	-3	-2	-5	-3	-1	-2	1,625
Income Tax Expense	0	0	0	-	-	-	-	-	-	382
Net Income	-5	-9	-4	-3	-2	-5	-3	-1	-2	1,243
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Enlivex Ltd. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	2	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-15	-5	-5	-8	-9	-19	-25	-29	-15	-15
EBITDA	-15	-5	-5	-9	-9	-18	-25	-28	-14	-14
Interest Expense	-	-	-	0	0	0	5	0	0	0
Depreciation	-	0	0	0	0	0	0	0	0	0
Income Before Tax	-15	-5	-4	-9	-11	-14	-31	-29	-15	1,618
Income Tax Expense	0	0	1	0	2	-4	11	4	-	382
Net Income	-16	-5	-4	-9	-11	-14	-31	-29	-15	1,235
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-519.28%	0.00%	0.00%	0.00%	0.00%	0.00%

Enlivex Ltd. Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-9	-4	-3	-2	-5	-3	-1	-2	1,243
Operating Cash Flow	-5	-4	-1	-2	-4	-4	-1	-2	-2
Investing Cash Flow	4	5	0	1	-	3	1	4	-9
Financing Cash Flow	0	0	4	0	1	0	0	0	10
Change in Cash	-1	1	1	0	0	-1	0	2	-2

Enlivex Ltd. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-5	-4	-9	-11	-14	-31	-29	-15	1,235
Operating Cash Flow	-6	-3	-7	-11	-17	-23	-23	-13	-10
Investing Cash Flow	3	0	-6	-20	-38	62	-25	9	-1
Financing Cash Flow	0	5	8	33	60	0	0	6	10
Change in Cash	-3	0	-4	1	4	38	-49	2	-1

Global Institutional Holdings in Enlivex Ltd.

Funds	Holdings
Springbok Capital Management, LLC	0.09%
Two Sigma Investments LLC	0.06%
JPMorgan Chase & Co	0.05%
MCGUIRE CAPITAL ADVISORS INC	0%
HRT FINANCIAL LLC	0.06%

See all

Insights on Enlivex Ltd.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 21.5% return, outperforming this stock by 74.0%
NO EFFECT
Against Peers
In the last 3 years, Enlivex Ltd. Ordinary Shares has experienced a drawdown of -78.7%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 69.1%
NEGATIVE IMPACT
Price Dip
In the last 1 month, ENLV stock has moved down by -25.4%

About Enlivex Ltd.

Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis, as well as develops AllocetraTM intra-articular injection for the treatment of knee osteoarthritis, which is in phase 1/2 trial; intra-articular AllocetraTM in osteoarthritis of the temporomandibular joint (TMJ); and Allocetra-OTS for the treatment of organ failure in adult sepsis patients, which is in phase 2. Enlivex Ltd. was formerly known as Enlivex Therapeutics Ltd. and changed its name to Enlivex Ltd. in February 2026. The company was founded in 2005 and is headquartered in Ness Ziona, Israel.

Organisation	Enlivex Ltd.
Headquarters	14 Einstein Street, Ness Ziona, Israel, 7403618
Industry	Biotechnology
CEO	Dr. Oren Hershkovitz Ph.D.
E-voting on shares	Click here to vote

Key Management of Enlivex Ltd.

Name	Title
Dr. Einat Galamidi M.D.	Chief Medical Officer
Mr. Shai Novik M.B.A.	Executive Chairman
Dr. Oren Hershkovitz Ph.D.	Chief Executive Officer
Prof. Dror Mevorach M.D.	Founder & Scientific Advisor
Ms. Shachar Shlosberger CPA	Chief Financial Officer
Dr. Veronique Amor-Baroukh	Senior Director of Operations
Ms. Sigal Arad	Director of Human Resources

FAQs

What is Enlivex Ltd. share price today?

Enlivex Ltd. share price today is $0.57 as on June 27, 2026 at 8:45 am IST at the close of the market. Enlivex Ltd. share today touched a day high of $0.6 and a low of $0.56.

What is the 52 week high and 52 week low for Enlivex Ltd. share?

Enlivex Ltd. share touched a 52 week high of $2.1 on August 15, 2025 and a 52 week low of $0.57 on June 25, 2026. Enlivex Ltd. stock price today i.e. June 27, 2026 at 8:45 am IST is closed at $0.57,which is 72.86% down from its 52 week high and 0.35% up from its 52 week low.

What is Enlivex Ltd.'s market capitalisation today?

Enlivex Ltd. market capitalisation is $0.00T as on June 27, 2026 at 8:45 am IST.

How to invest in Enlivex Ltd. Stock (ENLV) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Enlivex Ltd. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Enlivex Ltd. Shares that will get you 2.6316 shares as per Enlivex Ltd. share price of $0.57 per share as on June 27, 2026 at 8:45 am IST.

What is the minimum amount required to buy Enlivex Ltd. Stock (ENLV) from India?

Indian investors can start investing in Enlivex Ltd. (ENLV) shares with as little as ₹94.3 or $1 (as of June 29, 2026 at 3:03 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.00 in Enlivex Ltd. stock (as per the Rupee-Dollar exchange rate as on June 29, 2026 at 3:03 am IST). Based on Enlivex Ltd. share’s latest price of $0.57 as on June 27, 2026 at 8:45 am IST, you will get 17.5439 shares of Enlivex Ltd.. Learn more about fractional shares .

What are the returns that Enlivex Ltd. has given to Indian investors in the last 5 years?

Enlivex Ltd. stock has given -93.74% share price returns and 27.1% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?